[ Price : $8.95]
Ferring asks FDA to require ANDA sponsors to conduct clinical studies to demonstrate bioequivalence of a generic form of its colon...[ Price : $8.95]
Attorneys for a women who claims design defects in DePuy Pinnacle hips injured her and for the company debate the implants safety ...[ Price : $8.95]
FDA warns Beacon Hill Medical Pharmacy about CGMP and other violations in its production of compounded drugs.[ Price : $8.95]
FDAs Cincinnati District Office warns Western Enterprises/Scott Fetzer Company about QS violations in its manufacturing of medical...[ Price : $8.95]
FDA releases a final guidance on Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection that def...[ Price : $8.95]
Omeros Corp. suspends Huntingtons disease trials involving OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, as it fur...[ Price : $8.95]
FDA issues a letter of support for further exploration of two kidney biomarkers identified and evaluated by a Critical Path Instit...[ Price : $8.95]
A HHS OIG audit finds vulnerabilities in FDAs computer network that could make it vulnerable to hackers.